272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors

MLA

Pedro Romero, et al. “272 PD-L1 CAR Engineered K-NK Cells to Target PD-L1+ or PD-L1- Tumors.” Journal for ImmunoTherapy of Cancer, vol. 11, no. Suppl 1, Nov. 2023. EBSCOhost, https://doi.org/10.1136/jitc-2023-SITC2023.0272.

APA

Pedro Romero, Andre Kunert, Hardikkumar Jetani, Katarzyna Franciszkiewicz, David Vlerick, Aleksandra Nowicka, & Robert Y Igarashi. (2023). 272 PD-L1 CAR engineered K-NK cells to target PD-L1+ or PD-L1- tumors. Journal for ImmunoTherapy of Cancer, 11(Suppl 1). https://doi.org/10.1136/jitc-2023-SITC2023.0272

Chicago

Pedro Romero, Andre Kunert, Hardikkumar Jetani, Katarzyna Franciszkiewicz, David Vlerick, Aleksandra Nowicka, and Robert Y Igarashi. 2023. “272 PD-L1 CAR Engineered K-NK Cells to Target PD-L1+ or PD-L1- Tumors.” Journal for ImmunoTherapy of Cancer 11 (Suppl 1). doi:10.1136/jitc-2023-SITC2023.0272.